CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 19,142 shares at $2.93 ($56,086)
- 4 Open-market sale Director sold 4,720 shares at $2.97 ($14,018)
- 4 Open-market sale President and CEO sold 450,000 shares at $2.87 ($1,291,500)
- 4 Exercise or conversion Director acquired 24,720 shares (option exercise)
- 4 Exercise or conversion Director acquired 61,800 shares (option exercise)
- 4 Exercise or conversion Director acquired 24,720 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Sr Director Finance/Controller sold 6,000 shares at $2.23 ($13,380)
- 4 Exercise or conversion President and CEO acquired 15,450 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 6 of 36 · 720 filings